In this analysis, we found that the mean ALT for a child with NAFLD over 96 weeks discriminated well between those who progressed as defined by all four histologic assessments we tested (fibrosis, NAS, NASH, and NASH + fibrosis) compared to improvement. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.